Selegiline Alleviates the Depressive-Like Behaviors of Methamphetamine Withdrawal Syndrome Through Modulating Mitochondrial Function and Energy Hemostasis

Mir-Jamal Hosseini ^1,2 , Sima Askari Sadat-Mahaleh ^1,2, Hamed Ghavimi ^1,2 *

Cited by CrossRef: 3

1- Ghavimi H, Ebrahimi M, Hasanzadeh M, Lashgari A, Nedaei K, Kalantari Hesari A, Hosseini M. Neuroprotective Effects of Empagliflozin Against Methamphetamine-Induced Withdrawal Syndrome in Mice: Involvement of Bdnf, Tlr4, and JNK Signaling Pathways and Oxidative Stress Biomarkers. Iran J Pharm Res. 2026;25(1) [Crossref]

2- Hosseini M, Arabiyan A, Mobassem S, Ghavimi H. Metformin attenuates depressive-like behaviour of methamphetamine withdrawal in mice: A mechanistic approach. The World Journal of Biological Psychiatry. 2023;24(3):209 [Crossref]

3- Kumar J, Naina Mohamed I, Mohamed R, Ugusman A, Muzaimi M, Mohamed W, Yahaya M, Teoh S, Kamaluddin M, Abdul Hamid H, Mehat M, Shanmugam P. Locomotion changes in methamphetamine and amphetamine withdrawal: a systematic review. Front Pharmacol. 2024;15 [Crossref]

4- Hazani H, Naina Mohamed I, Muzaimi M, Mohamed W, Yahaya M, Teoh S, Pakri Mohamed R, Mohamad Isa M, Abdulrahman S, Ramadah R, Kamaluddin M, Kumar J. Goofballing of Opioid and Methamphetamine: The Science Behind the Deadly Cocktail. Front Pharmacol. 2022;13 [Crossref]

Indexing & Abstracting:

Follow us on LinkedIn
Follow us on Twitter